Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
基本信息
- 批准号:10394215
- 负责人:
- 金额:$ 59.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-19 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenosineAmericanBlood PressureBlood VolumeCardiovascular DiseasesComplications of Diabetes MellitusConsciousDevelopmentDiabetes MellitusDiabetic NephropathyDiabetic mouseEnd stage renal failureExcretory functionExhibitsFeedbackFunctional disorderGenerationsGeneticGlomerular Filtration RateGlucoseHyperglycemiaHypertensionImpairmentIn VitroInjury to KidneyInsulin-Dependent Diabetes MellitusJuxtaglomerular ApparatusKidneyLinkMacula densaMeasurementMeasuresMediatingMicropunctureMolecularMusNatriuresisNephronsNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INon-Insulin-Dependent Diabetes MellitusOxidesPatientsPharmacologyPhosphorylationPopulationProtein IsoformsRNA SplicingRoleSodiumTechniquesTestingTissuesUnited StatesVariantWaterarteriolebaseblood pressure elevationcardiovascular disorder riskcardiovascular risk factordiabeticdiabetic patientfluorescence imagingin vivoknockout animallaser capture microdissectionnew therapeutic targetnon-diabeticnovelpressureresponsesolute
项目摘要
There are more than 29 million Americans suffering from diabetes. About 30-40% of patients with diabetes
will eventually develop diabetic nephropathy, which is the leading cause of end stage renal disease in the United
States. The rate of hypertension is more than twice in diabetic patients than the non-diabetic population. Diabetic
patients with hypertension exhibit increased cardiovascular risk and exacerbation of diabetic nephropathy,
however, the mechanisms for hypertension in diabetic patients remains unclear.
The present proposal will test the central hypothesis that the increase of glucose concentration at the macula
densa in diabetes activates SGLT1, which enhances NOS1 activity and promotes the development of glomerular
hyperfiltration. Inadequate NO generation by the macula densa induces hypertension in diabetes and
exacerbates diabetic kidney injury by mechanisms of limiting elevations in GFR and impairing sodium excretion.
This hypothesis will be tested with the following specific aims:
Aim 1. Hypothesis: Glucose at the macula densa activates SGLT1 and enhances expression and activity of
macula densa NOS1 splice variants by phosphorylation of Ser1412. Blunted TGF responsiveness mediated by
the macula densa NOS1 promotes the development of hyperfiltration in type 1 and type 2 diabetes.
Aim 2. Hypothesis: Inadequate NO generation by the macula densa induces hypertension and exacerbates
diabetic kidney injury in type 1 and type 2 diabetes. The mechanism involved is that enhanced TGF response
limits the development of glomerular hyperfiltration, which impairs renal sodium excretion and pressure
natriuresis in diabetes.
有超过 2900 万美国人患有糖尿病。约30-40%的患者患有糖尿病
最终将发展为糖尿病肾病,这是美国终末期肾病的主要原因
国家。糖尿病患者的高血压发病率是非糖尿病人群的两倍多。糖尿病患者
高血压患者心血管风险增加,糖尿病肾病恶化,
然而,糖尿病患者高血压的机制仍不清楚。
本提案将检验中心假设,即黄斑处葡萄糖浓度的增加
糖尿病中的 densa 激活 SGLT1,从而增强 NOS1 活性,促进肾小球发育
超滤。致密黄斑生成的一氧化氮不足会诱发糖尿病和糖尿病患者的高血压
通过限制 GFR 升高和损害钠排泄的机制,加剧糖尿病肾损伤。
该假设将通过以下具体目标进行检验:
目标 1. 假设:致密斑处的葡萄糖激活 SGLT1 并增强 SGLT1 的表达和活性
Ser1412 磷酸化导致的致密斑 NOS1 剪接变体。 TGF 反应性减弱
致密斑 NOS1 促进 1 型和 2 型糖尿病过度滤过的发生。
目标 2. 假设:致密黄斑生成的 NO 不足会诱发高血压并加剧
1 型和 2 型糖尿病的糖尿病肾损伤。所涉及的机制是增强 TGF 反应
限制肾小球过度滤过的发展,从而损害肾钠排泄和压力
糖尿病中的尿钠排泄。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice.
他克莫司通过 RhoA(Ras 同源家族成员 A)/ROCK(Rho 相关蛋白激酶)通路增加小鼠血管收缩力,从而导致高血压。
- DOI:
- 发表时间:2022-10
- 期刊:
- 影响因子:0
- 作者:Wang, Xiaohua;Jiang, Shan;Fei, Lingyan;Dong, Fang;Xie, Lanyu;Qiu, Xingyu;Lei, Yan;Guo, Jie;Zhong, Ming;Ren, Xiaoqiu;Yang, Yi;Zhao, Liang;Zhang, Gensheng;Wang, Honghong;Tang, Chun;Yu, Luyang;Liu, Ruisheng;Patzak, Andreas;Persson, Pontus B
- 通讯作者:Persson, Pontus B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUISHENG LIU其他文献
RUISHENG LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUISHENG LIU', 18)}}的其他基金
Treatment of lupus nephritis with nanoparticles that selectively target kidney glomeruli
用选择性靶向肾小球的纳米颗粒治疗狼疮性肾炎
- 批准号:
10679184 - 财政年份:2023
- 资助金额:
$ 59.11万 - 项目类别:
Tubuloglomerular feedback response in AKI to CKD transition
AKI 向 CKD 转变中的肾小球反馈反应
- 批准号:
10533630 - 财政年份:2022
- 资助金额:
$ 59.11万 - 项目类别:
Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
- 批准号:
9917816 - 财政年份:2019
- 资助金额:
$ 59.11万 - 项目类别:
Renal hemodynamics and hypertension during pregnancy
妊娠期肾脏血流动力学和高血压
- 批准号:
10090619 - 财政年份:2018
- 资助金额:
$ 59.11万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8692309 - 财政年份:2014
- 资助金额:
$ 59.11万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8895614 - 财政年份:2014
- 资助金额:
$ 59.11万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
9282582 - 财政年份:2014
- 资助金额:
$ 59.11万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
9068089 - 财政年份:2014
- 资助金额:
$ 59.11万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8817288 - 财政年份:2014
- 资助金额:
$ 59.11万 - 项目类别:
Tubuloglomerular feedback and salt-sensitive hypertension
肾小球反馈和盐敏感性高血压
- 批准号:
8737891 - 财政年份:2013
- 资助金额:
$ 59.11万 - 项目类别:
相似国自然基金
腺苷酸转位酶在SARS-CoV-2感染中的作用及分子机制研究
- 批准号:32302955
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向RNA腺苷脱氨酶(ADAR1)的抑制剂发现与抗肿瘤活性研究
- 批准号:82304379
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
去腺苷酸化酶CNOT6L抑制结肠炎癌转化中CD8+T细胞功能的分子机制及其靶标属性探讨
- 批准号:82304557
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GelMA水凝胶负载腺苷经破骨细胞MAPK/AP1信号轴促进骨质疏松性颌骨缺损修复的研究
- 批准号:82301041
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
内含子多聚腺苷酸化介导的肿瘤易感基因的识别及调控模式研究
- 批准号:32370721
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
新型小分子稳定轴蛋白治疗非酒精性脂肪性肝炎
- 批准号:
10659312 - 财政年份:2023
- 资助金额:
$ 59.11万 - 项目类别:
CD39-carrying extracellular vesicles regulate pulmonary thrombosis in Sickle Cell Disease
携带CD39的细胞外囊泡调节镰状细胞病中的肺血栓形成
- 批准号:
10736531 - 财政年份:2023
- 资助金额:
$ 59.11万 - 项目类别:
AMPK localization, expression, and activity in Alzheimer's Disease
AMPK 在阿尔茨海默病中的定位、表达和活性
- 批准号:
10537142 - 财政年份:2022
- 资助金额:
$ 59.11万 - 项目类别:
Mechanisms of Somatostatin-Mediated Inhibition of Insulin and Glucagon
生长抑素介导的胰岛素和胰高血糖素抑制机制
- 批准号:
10537377 - 财政年份:2022
- 资助金额:
$ 59.11万 - 项目类别:
Effects of circadian desynchrony during adolescent alcohol exposure on immediate and long-term risk of alcohol addiction: role of sleep homeostasis and stress signaling
青少年酒精暴露期间昼夜节律不同步对酒精成瘾的近期和长期风险的影响:睡眠稳态和压力信号的作用
- 批准号:
10673146 - 财政年份:2022
- 资助金额:
$ 59.11万 - 项目类别: